Searchable abstracts of presentations at key conferences in endocrinology

ea0029p394 | Clinical case reports - Pituitary/Adrenal | ICEECE2012

Giant macroprolactinoma: recidive after 12 years (case report)

Loghin A. , Florescu A. , Grozavu I. , Haba D. , Apostu L. , Galesanu C.

Introduction: Prolactinomas are rare in childhood and adolescence, representing a half of pituitary adenomas (1% of intracranial tumors); macroadenomas are more frequent than microadenomas. The signs and symptoms depend on age, sex, tumor size and prolactin level. Due to a higher frequency of macroadenomas in boys, they present more often neuro-ophthalmologic findings (impaired vision, headache)Case report: We present a case of 25-year-old pacient diagno...

ea0029p397 | Clinical case reports - Pituitary/Adrenal | ICEECE2012

Macroprolactinomas: therapy compliance (case report)

Florescu A. , Loghin A. , Grozavu I. , Haba D. , Apostu L. , Galesanu C.

Prolactinomas represent 60% of primary pituitary tumors, galactorrrhoea and menstrual disturbances beeing the most frequent clinical features in women. The mass effect of macroadenomas is expressed by headache, visual field defects and hypopituitarism. The aims of therapy are reduction of tumour size, prevention of tumour expansion and restoration of gonadal function. Dopamine agonists normalize prolactin secretion and reduce tumour size in 40% of patients with macroadenoma.</...